Series: Practical guidance to qualitative research. Part 3: Sampling, data collection and analysis.
Albine Moser, Irene Korstjens
https://pubmed.ncbi.nlm.nih.gov/29199486/Actively Recruiting
Led by Germans Trias i Pujol Hospital · Updated on 2025-06-06
138
Participants Needed
1
Research Sites
108 weeks
Total Duration
This research is focused on women who have undergone mastectomy and are receiving nipple-areola complex reconstruction. It evaluates the impact of adding hyaluronic acid HA injections to standard areola micropigmentation. The study aims to understand effects on psychosocial and sexual well-being, satisfaction with breast and nipple appearance, and nipple projection. It uses a mixed-methods design, combining a randomized controlled trial with a qualitative study exploring patient experiences. Participants are divided into two groups one receiving only areola micropigmentation and the other receiving micropigmentation plus HA injections to enhance nipple projection. Micropigmentation is performed by trained nurses in outpatient settings over 2 to 4 sessions. For the HA group, injections are given 15 days after micropigmentation in 2 to 3 subcutaneous doses. Follow-up includes questionnaires and measurements immediately after the procedure, and at 3 and 6 months to assess satisfaction and HA retention. During the study, participants complete the Spanish BREAST-Q and custom satisfaction questionnaires. Nipple projection is measured with calipers. A subset of HA-treated participants will take part in interviews to discuss body image and emotional recovery. The primary outcome is satisfaction with nipple reconstruction at 3 and 6 months post-treatment. The total enrollment period extends over 36 months, with ethical approval and data security measures in place.
CONDITIONS
Impact of Nipple Reconstruction in Mastectomized Patients Using Cross-Linked Hyaluronic Acid Injection.
I
Isabel Granados Navarrete, RN
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Germans Trias i Pujol Hospital
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Approximately 1 to 2 months
Participants undergo areola micropigmentation in 2 to 4 sessions. Those in the intervention group receive subcutaneous injections of cross-linked hyaluronic acid filler 15 days after micropigmentation in 2 to 3 injections to restore nipple projection.
2 to 4 micropigmentation sessions and 1 to 3 hyaluronic acid injection visits depending on group assignment
Duration - Up to 6 months post-treatment
Participants complete questionnaires assessing satisfaction with nipple reconstruction, psychosocial and sexual well-being, and nipple projection measurements are taken to evaluate outcomes and retention of hyaluronic acid.
Visits at 3 months and 6 months after final injection session
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Albine Moser, Irene Korstjens
https://pubmed.ncbi.nlm.nih.gov/29199486/Ioannis Kyriazidis, Georgia-Alexandra Spyropoulou, George Zambacos...
https://pubmed.ncbi.nlm.nih.gov/37563436/A Sisti, L Grimaldi, J Tassinari...
https://pubmed.ncbi.nlm.nih.gov/26868167/Eric G Halvorson, Michael Cormican, Misti E West...
https://pubmed.ncbi.nlm.nih.gov/24776543/Mark A Boccola, Jessica Savage, Warren M Rozen...
https://pubmed.ncbi.nlm.nih.gov/20721849/Betty Bellman, Erika von Grote, Alessandra Nogueira
https://pubmed.ncbi.nlm.nih.gov/28961285/Paula Martínez, Jaime Jimeno, Fernando Hernanz...
https://pubmed.ncbi.nlm.nih.gov/36265774/Andrea Smallman, Tamara Crittenden, Jia MiinYip...
https://pubmed.ncbi.nlm.nih.gov/32158811/Gloria R Sue, Jennifer G Seither, Dung H Nguyen
https://pubmed.ncbi.nlm.nih.gov/32158901/Dina DiCenso, Erica Fischer-Cartlidge
https://pubmed.ncbi.nlm.nih.gov/26488844/Germans Trias i Pujol Hospital
Lead Sponsor